N-Desmethyl clomipramine hydrochloride
Based on 1 Customer Validation
N-Desmethyl clomipramine hydrochloride (Desmethylclomipramine hydrochloride; Norclomipramine hydrochloride) is the orally active major active metabolite of the tricyclic antidepressant Clomipramine (HY-B0457A), possessing multiple activities including anti-inflammatory, antioxidant, antibacterial, and antiparasitic effects. N-Desmethyl clomipramine hydrochloride blocks autophagosome-lysosome fusion, leading to the accumulation of LC3-II, p62, ATG7, WIPI2, and ATG5-12, reactivates the p53/p21 pathway, induces apoptosis through C-PARP and C-CAS3, and inhibits the proliferation, migration, and invasion of renal cancer cells. N-Desmethyl clomipramine hydrochloride inhibits LdTOPIA, inducing R-loop accumulation in the nucleus of Leishmania, ultimately causing parasite death. N-Desmethyl clomipramine hydrochloride can be used for research on depression, metastatic renal cell carcinoma, and leishmaniasis.
For research use only. We do not sell to patients.
- Purity : 99.78%
- CAS No.: 29854-14-6
- Formula: C18H22Cl2N2
- Molecular Weight:337.29
-
Storage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Biological Activity
Description
|
Caspase 3 |
PARP-1 |
TNF-α |
Leishmania |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| RAW264.7 | IC50 |
38.24 μM
|
Cytotoxicity against mouse Raw264.7 macrophages assessed as reduction in cell viability incubated for 72 hrs by modified MTT assay.
Cytotoxicity against mouse Raw264.7 macrophages assessed as reduction in cell viability incubated for 72 hrs by modified MTT assay.
|
38484800 |
| THP-1 | IC50 |
40 μM
|
Cytotoxicity against human THP1 macrophages assessed as reduction in cell viability incubated for 72 hrs by modified MTT assay.
Cytotoxicity against human THP1 macrophages assessed as reduction in cell viability incubated for 72 hrs by modified MTT assay.
|
38484800 |
In Vitro
N-Desmethyl clomipramine (Norclomipramine) hydrochloride completely inhibits Mycobacterium tuberculosis topoisomerase-I activity in the DNA relaxation assay[2].
N-Desmethyl clomipramine hydrochloride effectively blocks autophagic flux in KJ29 and Caki-2 ccRCC cells, leading to the accumulation of the autophagy markers p62 and LC3I/II; it also prevents autophagosome-lysosome fusion, resulting in the accumulation of ATG7, WIPI2, and ATG5-12 in KJ29 and Caki-2 ccRCC cells[3].
N-Desmethyl clomipramine (1-10 µM; 0-120 h) hydrochloride inhibits the proliferation of KJ29 and Caki-2 ccRCC cells in a dose-dependent manner, reduces migration, and enhances the growth-inhibitory effect of Sunitinib (HY-10255A); it also promotes apoptosis in KJ29 and Caki-2 ccRCC cells and enhances Sunitinib-induced apoptosis through activation of C-PARP and C-CAS3[3].
N-Desmethyl clomipramine (5 µM) hydrochloride inhibits autophagy and reactivates the p53/p21 pathway in KJ29 and Caki-2 ccRCC cells[3].
N-Desmethyl clomipramine (Desmethylclomipramine) (0.01-1 μM; 48 h) hydrochloride reduces TNFα secretion and nitrite levels in a dose-dependent manner in mouse primary cortical neuron-BV2 microglia co-cultures, but does not improve neuronal viability[4].
N-Desmethyl clomipramine (1 μM; 16 h) hydrochloride upregulates Nfe2l2 gene expression in BV2 microglia under both inflammatory and non-inflammatory conditions, but does not regulate the expression of the Nrf2 target genes Gclm, Hmox1, or Nqo1[4].
N-Desmethyl clomipramine (10-40 μM) hydrochloride inhibits the DNA relaxation activity of LdTOPIA[5].
N-Desmethyl clomipramine (2-100 μM; 72 h) hydrochloride exhibits potent antileishmanial activity against Leishmania donovani promastigotes and amastigotes, and is effective against clinically isolated antimony-resistant Leishmania isolates BHU575 and BHU814; its cytotoxicity to macrophages (Raw264.7 and THP1) is lower than its antileishmanial activity[5].
N-Desmethyl clomipramine (10 μM; 0-48 h) hydrochloride treatment induces R-loop formation in Leishmania donovani DD8 parasites, as detected by the DRIB assay[5].
N-Desmethyl clomipramine (10 μM; 6-48 h) hydrochloride effectively clears Leishmania donovani DD8 amastigotes within RAW264.7 macrophages[5].
N-Desmethyl clomipramine (10 μM; 48 h) hydrochloride reduces the intracellular amastigote burden of Leishmania donovani DD8, BHU575, and BHU814 in RAW264.7 macrophages[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 29854-14-6
-
Appearance Solid
-
Molecular Weight 337.29
-
Formula C18H22Cl2N2
-
Color White to pink
-
SMILES
CNCCCN1C2=CC(Cl)=CC=C2CCC3=CC=CC=C31.[H]Cl
-
Synonyms
Desmethylclomipramine hydrochloride; Norclomipramine hydrochloride
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
In Vitro:
DMSO : 25 mg/mL (74.12 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell invasion
Cell invasion is the ability of cells to migrate from one area to another via the extracellular matrix. Cell invasion is the response of normal and cancer cells to chemical and mechanical stimuli. Before migrating to a new region, the extracellular matrix is degraded by proteases within the cell. Cell invasion often occurs during wound repair, vascularization and inflammation, abnormal tissue invasion, and tumor cell metastasis.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (296 KB)
-
SDS (459 KB)
- English - EN (459 KB)
- Français - FR (459 KB)
- Deutsch - DE (459 KB)
- Norwegian - NO (459 KB)
- Español - ES (459 KB)
- Swedish - SV (459 KB)
- Italian - IT (459 KB)
- Korean - KR (459 KB)
- Portuguese - PT (459 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.9648 mL | 14.8240 mL | 29.6481 mL | 74.1202 mL |
| 5 mM | 0.5930 mL | 2.9648 mL | 5.9296 mL | 14.8240 mL | |
| 10 mM | 0.2965 mL | 1.4824 mL | 2.9648 mL | 7.4120 mL | |
| 15 mM | 0.1977 mL | 0.9883 mL | 1.9765 mL | 4.9413 mL | |
| 20 mM | 0.1482 mL | 0.7412 mL | 1.4824 mL | 3.7060 mL | |
| 25 mM | 0.1186 mL | 0.5930 mL | 1.1859 mL | 2.9648 mL | |
| 30 mM | 0.0988 mL | 0.4941 mL | 0.9883 mL | 2.4707 mL | |
| 40 mM | 0.0741 mL | 0.3706 mL | 0.7412 mL | 1.8530 mL | |
| 50 mM | 0.0593 mL | 0.2965 mL | 0.5930 mL | 1.4824 mL | |
| 60 mM | 0.0494 mL | 0.2471 mL | 0.4941 mL | 1.2353 mL |
Keywords
- N-Desmethyl clomipramine
- 29854-14-6
- Desmethylclomipramine
- Norclomipramine
- Drug Metabolite
- Atg8/LC3
- p62
- Atg7
- MDM-2/p53
- PAK
- Caspase
- PARP
- TNF Receptor
- Parasite
- Bacterial
- Autophagy
- Apoptosis
- BV2 microglia
- Leishmania donovani
- Nfe2l2
- KJ29
- NET
- THP1
- RAW264.7
- ccRCC cells
- Caki-2
- Mycobacterium tuberculosis topoisomerase-I
- Inhibitor
- inhibitor
- inhibit